CENTENE CORPORATION
Hospital & Medical Service Plans- 売上
- $175bn
- 時価総額
- $30.2bn
株価 $60.84 · 100株 6,084円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $140bn | $146bn | $175bn |
| 成長率 | — | 3.9% | 20.0% |
| 総利益 | $17.6bn | $17.1bn | $14.2bn |
| 総利益率 | 12.6% | 11.7% | 8.1% |
| 販管費 | $12.6bn | $12.4bn | $12.9bn |
| 販管費率 | 9.0% | 8.5% | 7.4% |
| 営利 | $2.9bn | $3.2bn | ▲$7.6bn |
| 営利率 | 2.1% | 2.2% | ▲4.4% |
| 純利益 | $2.7bn | $3.3bn | ▲$6.7bn |
| PBR | 1.2 | 1.1 | 1.5 |
| PSR | 0.2 | 0.2 | 0.2 |
| PGPR | 1.7 | 1.8 | 2.1 |
| PER | 11 | 9 | — |
| ネットキャッシュ | ▲$636m | ▲$4.5bn | $487m |
| EV/EBITDA | 7.3 | 7.8 | — |
| Rule of 40 | — | 6% | 16% |
| セールス効率 | — | — | ▲568% |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
